4.7 Article

The Allium Derivate Propyl Propane Thiosulfinate Exerts Anti-Obesogenic Effects in a Murine Model of Diet-Induced Obesity

Journal

NUTRIENTS
Volume 14, Issue 3, Pages -

Publisher

MDPI
DOI: 10.3390/nu14030440

Keywords

obesity; microbiota; propyl propane thiosulfinate; Allium; dose effect

Funding

  1. Spanish Ministry of Science and Innovation (MICINN) [PID2020-119536RB-I00, CIEN IDI-20170847]
  2. Spanish Ministry of Universities [FPU 18/02026]
  3. contract Juan de la Cierva-Incorporacion [IJCI-2017-32485]

Ask authors/readers for more resources

In this study, propyl propane thiosulfinate (PTS) showed dose-dependent anti-obesogenic effects in a murine model of diet-induced obesity. PTS prevented weight gain, adipocyte enlargement, inflammation, and gut barrier dysfunction caused by the obesogenic diet. The higher dose of PTS also improved glucose metabolism, liver homeostasis, lipid metabolism, and thermogenic capacity of brown adipose tissue.
Allium species and their organosulfur-derived compounds could prevent obesity and metabolic dysfunction, as they exhibit immunomodulatory and antimicrobial properties. Here, we report the anti-obesogenic potential and dose-dependent effects (0.1 or 1 mg/kg/day) of propyl propane thiosulfinate (PTS) in a murine model of diet-induced obesity. The obesogenic diet increased body weight gain and adipocyte size, and boosted inflammatory marker (Cd11c) expression in the adipose tissue. Conversely, PTS prevented these effects in a dose-dependent manner. Moreover, the higher dose of PTS improved glucose and hepatic homeostasis, modulated lipid metabolism, and raised markers of the thermogenic capacity of brown adipose tissue. In the colon, the obesogenic diet reduced IL-22 levels and increased gut barrier function markers (Cldn3, Muc2, Reg3g, DefaA); however, the highest PTS dose normalized all of these markers to the levels of mice fed a standard diet. Gut microbiota analyses revealed no differences in diversity indexes and only minor taxonomic changes, such as an increase in butyrate producers, Intestimonas and Alistipes, and a decrease in Bifidobacterium in mice receiving the highest PTS dose. In summary, our study provides preclinical evidence for the protective effects of PTS against obesity, which if confirmed in humans, might provide a novel plant-based dietary product to counteract this condition.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.7
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available